Compare ILMN & FTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ILMN | FTAI |
|---|---|---|
| Founded | 1998 | 2011 |
| Country | United States | United States |
| Employees | N/A | 985 |
| Industry | Medical Specialities | Misc Corporate Leasing Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.7B | 23.4B |
| IPO Year | 2000 | N/A |
| Metric | ILMN | FTAI |
|---|---|---|
| Price | $190.46 | $207.98 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 17 | 9 |
| Target Price | $124.24 | ★ $274.67 |
| AVG Volume (30 Days) | ★ 1.9M | 1.1M |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.75% |
| EPS Growth | ★ 170.87 | N/A |
| EPS | ★ 0.87 | N/A |
| Revenue | ★ $4,343,000,000.00 | N/A |
| Revenue This Year | $6.47 | $32.73 |
| Revenue Next Year | $5.58 | $51.41 |
| P/E Ratio | $213.44 | ★ $65.85 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $88.00 | $109.90 |
| 52 Week High | $196.66 | $323.51 |
| Indicator | ILMN | FTAI |
|---|---|---|
| Relative Strength Index (RSI) | 51.53 | 37.03 |
| Support Level | $116.54 | $157.96 |
| Resistance Level | $196.66 | $269.05 |
| Average True Range (ATR) | 6.46 | 14.03 |
| MACD | -1.84 | -3.75 |
| Stochastic Oscillator | 24.03 | 8.14 |
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
FTAI Aviation Ltd is an independent engine maintenance platform focused on the CFM56-5B, CFM56-7B, and V2500 aircraft engines, which power the 737NG and A320ceo aircraft. The company repairs and rebuilds engines in its maintenance facilities and with joint venture partners, and sells or leases engines through its proprietary Maintenance, Repair and Exchange (MRE) model under the Aerospace Products segment, which earns maximum revenue from North America and develops, repairs/refurbishes, and sells aircraft engines and aftermarket components. It also operates an Aviation Leasing segment, owning and managing a portfolio of on- and off-lease aircraft and engines, including engine transfers for rebuilding and sales.